Takeda Pharmaceutical
306 hedge funds and large institutions have $1.98B invested in Takeda Pharmaceutical in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 75 increasing their positions, 100 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
306
Holders Change
-4
Holders Change %
-1.29%
% of All Funds
6.29%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.14%
New
39
Increased
75
Reduced
100
Closed
41
Calls
$57.8M
Puts
$66.4M
Net Calls
-$8.63M
Net Calls Change
-$75K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$33.1M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$16.1M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$8.42M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$7.59M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.24M |
Top Sellers
| 1 |
GCM
Glenview Capital Management
New York
|
-$67.4M |
| 2 |
PC
Paulson & Co
New York
|
-$31.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$20.4M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$15.1M |
| 5 |
CCM
Causeway Capital Management
Los Angeles,
California
|
-$11.3M |
